Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs

Parkinson’s disease (PD) affects around ten million people worldwide and is considered the second most prevalent neurodegenerative disease after Alzheimer’s disease. In addition, there is a higher risk incidence in the elderly population. The main PD hallmarks include the loss of dopaminergic neuron...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Sara, Almeida, António J., Vale, Nuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068059/
https://www.ncbi.nlm.nih.gov/pubmed/33917696
http://dx.doi.org/10.3390/pharmaceutics13040508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068059/
https://www.ncbi.nlm.nih.gov/pubmed/33917696
http://dx.doi.org/10.3390/pharmaceutics13040508

Ejemplares similares